Stockreport

Astellas Presents Scientific Progress in Advanced and Hard-to-Treat Cancers at ESMO 2024

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors